Literature DB >> 19083437

Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats.

Maísa Silva1, Marcelo E Silva, Heberth de Paula, Cláudia Martins Carneiro, Maria Lucia Pedrosa.   

Abstract

The objective of this study was to investigate the effect of iron overload with a hyperlipidemic diet on the histologic feature of hepatic tissue, the lipid and glycemic serum profiles, and the markers of oxidative damage and stress in a rat model. Twenty-four male Fischer rats, purchased from Experimental Nutrition Laboratory, Federal University of Ouro Preto, were assigned to 4 equal groups, 2 were fed a standard cholesterol-free diet (group C or control and CI or control with iron) containing 8.0% soybean oil and 2 were fed a hyperlipidemic diet (group H or hyperlipidemic and HI or hyperlipidemic with iron) containing 1.0% cholesterol and 25.0% soybean oil. A total of 50 mg of iron was administered to rats in groups CI and HI in 5 equal doses (1 every 3 weeks for a 16-week period) by intraperitoneal injections of 0.1 mL of iron dextran solution (100 g Fe(2+)/L; Sigma, St Louis, Mo). The other rats in groups C and H were treated in a similar manner but with sterile saline (0.1 mL). Irrespective of the diet, iron excess enhanced serum triacylglycerols (P < .05) and reduced serum glucose and glycated hemoglobin levels (P < .05) but did not affect serum cholesterol concentration. Histologic analysis showed steatosis in groups H and to a lesser extent in HI. No significant differences (P > .05) were observed in paraoxonase activities or in serum levels of free or total sulfhydryl radicals, malondialdehyde, or total antioxidants. The findings suggest that iron excess in the rat probably modifies lipid metabolism and, as a consequence, alters glucose homeostasis and increases the level of serum triacylglycerols but not of cholesterol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083437     DOI: 10.1016/j.nutres.2008.02.009

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  17 in total

1.  Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source.

Authors:  Lara M Mangravite; Sally Chiu; Kathleen Wojnoonski; Robin S Rawlings; Nathalie Bergeron; Ronald M Krauss
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

Review 2.  Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ruben Hernaez; Edwina Yeung; Jeanne M Clark; Kris V Kowdley; Frederick L Brancati; Wen Hong Linda Kao
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

Review 3.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

4.  Biochemical and histological liver changes occurred after iron supplementation and possible remediation by garlic consumption.

Authors:  Héla Ghorbel; Ines Feki; Ines Friha; Abdel Majid Khabir; Tahya Boudawara; Mohamed Boudawara; Sami Sayadi
Journal:  Endocrine       Date:  2011-05-08       Impact factor: 3.633

5.  Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.

Authors:  Jonghan Kim; Xuming Jia; Peter D Buckett; Sihao Liu; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2012-12-14       Impact factor: 5.191

6.  The impact of iron content in a diet high in fat, fructose, and salt on metabolic state and mineral status of rats.

Authors:  Joanna Suliburska
Journal:  J Physiol Biochem       Date:  2013-07-20       Impact factor: 4.158

7.  The influence of liver fat deposition on the quantification of the liver-iron fraction using fast-kilovolt-peak switching dual-energy CT imaging and material decomposition technique: an in vitro experimental study.

Authors:  Tingting Xie; Yongbin Li; Guanyong He; Zhen Zhang; Qiao Shi; Guanxun Cheng
Journal:  Quant Imaging Med Surg       Date:  2019-04

Review 8.  Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets.

Authors:  Long-Xia Li; Fang-Fang Guo; Hong Liu; Tao Zeng
Journal:  Cell Mol Life Sci       Date:  2022-03-24       Impact factor: 9.261

9.  Effects of the interaction of diabetes and iron supplementation on hepatic and pancreatic tissues, oxidative stress markers, and liver peroxisome proliferator-activated receptor-α expression.

Authors:  Maísa Silva; Larissa de Freitas Bonomo; Riva de Paula Oliveira; Wanderson Geraldo de Lima; Marcelo Eustáquio Silva; Maria Lucia Pedrosa
Journal:  J Clin Biochem Nutr       Date:  2011-06-04       Impact factor: 3.114

Review 10.  Atherogenesis and iron: from epidemiology to cellular level.

Authors:  Francesca Vinchi; Martina U Muckenthaler; Milene C Da Silva; György Balla; József Balla; Viktória Jeney
Journal:  Front Pharmacol       Date:  2014-05-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.